Thromb Haemost 2000; 84(01): 98-103
DOI: 10.1055/s-0037-1613975
Commentary
Schattauer GmbH

Monoclonal Antibodies against Platelet Membrane Glycoproteins IIb/IIIa and Ibα Inhibit Platelet Dependent Thrombin Generation by Different Mechanisms

Stephen Thomas
2   From the Division of Haematology, National Institute for Biological Standards and Control, Hertfordshire, UK
,
Paul Metcalfe
2   From the Division of Haematology, National Institute for Biological Standards and Control, Hertfordshire, UK
,
Alison H. Goodall
1   Division of Chemical Pathology, University of Leicester, Leicester, UK
,
Elaine Gray
2   From the Division of Haematology, National Institute for Biological Standards and Control, Hertfordshire, UK
› Author Affiliations
Further Information

Publication History

Received 02 August 1999

Accepted after resubmission 21 February 2000

Publication Date:
10 December 2017 (online)

Preview

Summary

The antithrombotic effect of antiplatelet agents is principally due to their anti-aggregatory action, but these agents may also interfere with coagulation. We have investigated the effect of monoclonal antibodies (MAb) to platelet membrane glycoproteins (GP) IIb/IIIa and Iba on thrombin generation.

Antibodies to platelet membrane glycoprotein IIb/IIIa (RFGP56 and c7E3) were shown to inhibit platelet-mediated thrombin generation stimulated by both intrinsic and extrinsic methods. An antibody to GP Ibα (RFGP37) also inhibited thrombin generation in these systems.

FITC-annexin V was used to determine the effect of these antibodies on the exposure of procoagulant phospholipids on the platelet membrane, and it was found that the anti-IIb/IIIa antibodies reduced this, whereas the anti-Ibα antibody caused an increase.

We conclude that our monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibα inhibit platelet dependent thrombin generation by different mechanisms.